CINXE.COM

Embracing AI & Emerging Technologies to Advance Cancer Care Oncology │ Leadership │ Article │ Data

<!DOCTYPE html><html><head><meta charSet="utf-8"/><meta name="viewport" content="user-scalable=yes, width=device-width, initial-scale=1, maximum-scale=2, viewport-fit=cover"/><link href="https://takeda-mo.mo.cloudinary.net" rel="dns-prefetch"/><link href="https://takeda-mo.mo.cloudinary.net" rel="preconnect"/><style>:root { --colorPrimary:#bd120a; --textColor:#333333; --colorMediumGrey:#8289A5; --colorDarkGrey:#34373f; --colorSecondary:#ffffff; --colorMediumGreyContrast:#ffffff; --colorLightGreyContrast:#34373f; --colorSecondaryContrast:#34373f; --colorPrimaryContrast:#ffffff; --colorPrimaryActive:#891515; --colorPrimaryActiveContrast:#ffffff; --colorDarkGreyContrast:#ffffff; --colorLightGrey:#edf2f4; }</style><link rel="preload" href="/fonts/woff2/GothamSSm-Book_Web.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="shortcut icon" href="/favicon.ico"/><link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png"/><title>Embracing AI &amp; Emerging Technologies to Advance Cancer Care Oncology │ Leadership │ Article │ Data</title><meta name="robots" content="index,follow"/><meta name="description" content="Technological advances continue to push the boundaries of what&#x27;s possible. Takeda&#x27;s Teresa Bitetti discusses how we are leveraging these tools for cancer patients."/><meta property="og:title" content="Embracing AI &amp; Emerging Technologies to Advance Cancer Care Oncology │ Leadership │ Article │ Data"/><meta property="og:description" content="Technological advances continue to push the boundaries of what&#x27;s possible. Takeda&#x27;s Teresa Bitetti discusses how we are leveraging these tools for cancer patients."/><meta property="og:url" content="https://www.takedaoncology.com/news/our-viewpoints/embracing-AI-emerging-technologies-to-advance-cancer-care"/><meta property="og:image" content="http://assets-dam.takeda.com/image/upload/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png"/><meta property="og:image:alt" content="Embracing AI &amp; Emerging Technologies to Advance Cancer Care Oncology │ Leadership │ Article │ Data"/><meta property="og:image:secure_url" content="https://assets-dam.takeda.com/image/upload/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png"/><meta property="og:image:type" content="image"/><meta property="og:image:width" content="1920"/><meta property="og:image:height" content="1080"/><link rel="canonical" href="https://www.takedaoncology.com/news/our-viewpoints/embracing-AI-emerging-technologies-to-advance-cancer-care"/><meta name="next-head-count" content="21"/><script defer="" data-nscript="beforeInteractive"> window.aimDataLayer = window.aimDataLayer || []; function aimTag() { aimDataLayer.push(arguments); } // Transition event is temporary during a limited period of time to allow us to pull application cache from Legacy AIM Reader (v2) over to AIM Tag (v4) aimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'transition'); aimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'pageview'); // If your contract includes signal, then callback will include personal information on the visitor aimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'signal', function(err, success) { if (err) { // This will occur if we disable your API Key console.log(err); } else { console.log(success); if (success.identity_type === "AUT") { // Handle signal callback here } } }); </script><script defer="" type="text/javascript" data-nscript="beforeInteractive"> function OptanonWrapper() { } </script><script data-nscript="beforeInteractive">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WLM2GHB');</script><script data-nscript="beforeInteractive"> var _mtm = window._mtm = window._mtm || []; _mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'}); var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_8RFPFIX1.js'; s.parentNode.insertBefore(g,s); </script><script data-nscript="beforeInteractive"> (function(h,o,u,n,d) { h=h[d]=h[d]||{q:[],onReady:function(c){h.q.push(c)}} d=o.createElement(u);d.async=1;d.src=n n=o.getElementsByTagName(u)[0];n.parentNode.insertBefore(d,n) })(window,document,'script','https://www.datadoghq-browser-agent.com/datadog-rum-v4.js','DD_RUM') DD_RUM.onReady(function() { DD_RUM.init({ applicationId: 'cb52b5d9-3959-4471-83ab-4d3b7fc4413d', clientToken: 'pub03db37541acbf5d3c9cd0527f1ec4fcd', site: 'datadoghq.com', service: 'www.takedaoncology.com', env: 'prd', sampleRate: 100, sessionReplaySampleRate: 10, trackUserInteractions: true, trackResources: true, trackLongTasks: true, }); DD_RUM.startSessionReplayRecording(); }) </script><link rel="preload" href="/_next/static/css/c519d5e30826dfa8.css" as="style"/><link rel="stylesheet" href="/_next/static/css/c519d5e30826dfa8.css" data-n-g=""/><link rel="preload" href="/_next/static/css/c6727958a5da520b.css" as="style"/><link rel="stylesheet" href="/_next/static/css/c6727958a5da520b.css"/><link rel="preload" href="/_next/static/css/f714de409d1b43fb.css" as="style"/><link rel="stylesheet" href="/_next/static/css/f714de409d1b43fb.css"/><link rel="preload" href="/_next/static/css/99f1298953809fb9.css" as="style"/><link rel="stylesheet" href="/_next/static/css/99f1298953809fb9.css"/><link rel="preload" href="/_next/static/css/8a81431e0111eb38.css" as="style"/><link rel="stylesheet" href="/_next/static/css/8a81431e0111eb38.css"/><link rel="preload" href="/_next/static/css/ed452b8d3cb9b5f5.css" as="style"/><link rel="stylesheet" href="/_next/static/css/ed452b8d3cb9b5f5.css"/><link rel="preload" href="/_next/static/css/809612daef445aa2.css" as="style"/><link rel="stylesheet" href="/_next/static/css/809612daef445aa2.css"/><link rel="preload" href="/_next/static/css/35f0bf5638c2f65f.css" as="style"/><link rel="stylesheet" href="/_next/static/css/35f0bf5638c2f65f.css"/><link rel="preload" href="/_next/static/css/3357360309553917.css" as="style"/><link rel="stylesheet" href="/_next/static/css/3357360309553917.css"/><link rel="preload" href="/_next/static/css/334b3874b222d47d.css" as="style"/><link rel="stylesheet" href="/_next/static/css/334b3874b222d47d.css"/><link rel="preload" href="/_next/static/css/9f82b9d0d0c21666.css" as="style"/><link rel="stylesheet" href="/_next/static/css/9f82b9d0d0c21666.css"/><link rel="preload" href="/_next/static/css/d95ed4d36274837d.css" as="style"/><link rel="stylesheet" href="/_next/static/css/d95ed4d36274837d.css"/><link rel="preload" href="/_next/static/css/cb5012c0c2e9150c.css" as="style"/><link rel="stylesheet" href="/_next/static/css/cb5012c0c2e9150c.css"/><link rel="preload" href="/_next/static/css/9d119ba58dd11c66.css" as="style"/><link rel="stylesheet" href="/_next/static/css/9d119ba58dd11c66.css"/><link rel="preload" href="/_next/static/css/aa226ccbec964fd3.css" as="style"/><link rel="stylesheet" href="/_next/static/css/aa226ccbec964fd3.css"/><link rel="preload" href="/_next/static/css/61d67fc7d820ece5.css" as="style"/><link rel="stylesheet" href="/_next/static/css/61d67fc7d820ece5.css"/><link rel="preload" href="/_next/static/css/ec29553974346451.css" as="style"/><link rel="stylesheet" href="/_next/static/css/ec29553974346451.css"/><link rel="preload" href="/_next/static/css/f544ebc22208d8fd.css" as="style"/><link rel="stylesheet" href="/_next/static/css/f544ebc22208d8fd.css"/><link rel="preload" href="/_next/static/css/6ff744ee6873a788.css" as="style"/><link rel="stylesheet" href="/_next/static/css/6ff744ee6873a788.css"/><link rel="preload" href="/_next/static/css/46cb5e24335d01a0.css" as="style"/><link rel="stylesheet" href="/_next/static/css/46cb5e24335d01a0.css"/><link rel="preload" href="/_next/static/css/08eb4b1e92fe81cb.css" as="style"/><link rel="stylesheet" href="/_next/static/css/08eb4b1e92fe81cb.css"/><link rel="preload" href="/_next/static/css/15ef2fffadd72147.css" as="style"/><link rel="stylesheet" href="/_next/static/css/15ef2fffadd72147.css"/><link rel="preload" href="/_next/static/css/d5a466a385fa8ca2.css" as="style"/><link rel="stylesheet" href="/_next/static/css/d5a466a385fa8ca2.css"/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer&amp;target=ie11" defer="" nomodule="" data-nscript="beforeInteractive"></script><script src="https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer" defer="" type="module" data-nscript="beforeInteractive"></script><script src="https://cdn.cookielaw.org/consent/1c21da89-fd19-457f-a6d0-69a1c4fead2d/OtAutoBlock.js" defer="" type="text/javascript" data-nscript="beforeInteractive"></script><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" defer="" data-document-language="true" type="text/javascript" charSet="UTF-8" data-domain-script="1c21da89-fd19-457f-a6d0-69a1c4fead2d" data-nscript="beforeInteractive"></script><script defer="" src="/_next/static/chunks/8913.8618515d6a868dda.js"></script><script defer="" src="/_next/static/chunks/1735.6e13465857a46e49.js"></script><script defer="" src="/_next/static/chunks/982.49d90b2e7c60d920.js"></script><script defer="" src="/_next/static/chunks/29107295.54c46f60208f68c8.js"></script><script defer="" src="/_next/static/chunks/3707.581b5e92eb05e247.js"></script><script defer="" src="/_next/static/chunks/8378.275f2173944fc013.js"></script><script defer="" src="/_next/static/chunks/1467.47739fc584c2757a.js"></script><script defer="" src="/_next/static/chunks/4676.f60b29e1327e8187.js"></script><script defer="" src="/_next/static/chunks/9669.c8815bc7bc3ead79.js"></script><script defer="" src="/_next/static/chunks/8212.48487cb9786df9db.js"></script><script defer="" src="/_next/static/chunks/9327.f98e8218a85cc756.js"></script><script defer="" src="/_next/static/chunks/8079.27f1c84ee15713c1.js"></script><script defer="" src="/_next/static/chunks/738.f9148f949790a9ae.js"></script><script defer="" src="/_next/static/chunks/675.a1a1af359fe4d930.js"></script><script defer="" src="/_next/static/chunks/286.3545219d6ff7852f.js"></script><script defer="" src="/_next/static/chunks/2066.c95332614bc5ec40.js"></script><script defer="" src="/_next/static/chunks/3829.7b1cdd8ec4cb42d9.js"></script><script defer="" src="/_next/static/chunks/7588.a4ac813d2e46add1.js"></script><script defer="" src="/_next/static/chunks/4818.bb240cb895090fe6.js"></script><script defer="" src="/_next/static/chunks/6456.9e17dc67d9034b8a.js"></script><script defer="" src="/_next/static/chunks/9413.99fc3b9a6a9bfe5b.js"></script><script defer="" src="/_next/static/chunks/8660.4a197c146bc5993e.js"></script><script defer="" src="/_next/static/chunks/288.1751a2b1b675e888.js"></script><script defer="" src="/_next/static/chunks/5186.4785dac5822b21c3.js"></script><script defer="" src="/_next/static/chunks/3644.41c81531f05f80c9.js"></script><script defer="" src="/_next/static/chunks/2070.286ed26b343b5f52.js"></script><script defer="" src="/_next/static/chunks/9838.34be64ecf5398e95.js"></script><script defer="" src="/_next/static/chunks/7073.54007dece5d1a0d2.js"></script><script defer="" src="/_next/static/chunks/7158.d421ca46974c78df.js"></script><script defer="" src="/_next/static/chunks/9634.a0250f8010de76bc.js"></script><script defer="" src="/_next/static/chunks/5365.e047e93261dea455.js"></script><script defer="" src="/_next/static/chunks/8702.ac751862c703397f.js"></script><script defer="" src="/_next/static/chunks/6787.8943caa843771f4f.js"></script><script defer="" src="/_next/static/chunks/8242.8d79e95aa78881d5.js"></script><script defer="" src="/_next/static/chunks/1118.b7a94127c8bbafda.js"></script><script defer="" src="/_next/static/chunks/4576.f5e56d80d185d5eb.js"></script><script defer="" src="/_next/static/chunks/4330.87de35eca2266ce4.js"></script><script defer="" src="/_next/static/chunks/81.2e2b8e509d20ba66.js"></script><script defer="" src="/_next/static/chunks/4432.71a8bcdbb217fb55.js"></script><script defer="" src="/_next/static/chunks/3978.22ca6ffb07e5e6dc.js"></script><script defer="" src="/_next/static/chunks/5724.5488b2011e94cf31.js"></script><script defer="" src="/_next/static/chunks/5866.0eac23fb033fc3f1.js"></script><script defer="" src="/_next/static/chunks/7133.6baf6024d2fdc8bc.js"></script><script defer="" src="/_next/static/chunks/8657.943f848c2c34bd7a.js"></script><script defer="" src="/_next/static/chunks/8091.763061629e64ad5c.js"></script><script defer="" src="/_next/static/chunks/3085.1e018d7cfcba1d94.js"></script><script defer="" src="/_next/static/chunks/812.bc3fd270f49cb973.js"></script><script defer="" src="/_next/static/chunks/5657.b3bba6461071e4ec.js"></script><script defer="" src="/_next/static/chunks/1078.da84bc00ff6589a4.js"></script><script defer="" src="/_next/static/chunks/7557.1da5eb9c852f6287.js"></script><script defer="" src="/_next/static/chunks/283.12886359ee935697.js"></script><script defer="" src="/_next/static/chunks/5298.52a7022d1727d611.js"></script><script defer="" src="/_next/static/chunks/3029.f552db69430d366e.js"></script><script defer="" src="/_next/static/chunks/6362.eff60ce13337ecb7.js"></script><script defer="" src="/_next/static/chunks/9457.ace3bca4eac3ffb2.js"></script><script src="/_next/static/chunks/webpack-008ddd2f41b3e2e6.js" defer=""></script><script src="/_next/static/chunks/framework-ce84985cd166733a.js" defer=""></script><script src="/_next/static/chunks/main-d09ace4de2a9c53e.js" defer=""></script><script src="/_next/static/chunks/pages/_app-cd716749cbc36f2c.js" defer=""></script><script src="/_next/static/chunks/pages/%5B%5B...slug%5D%5D-d1ed8493a45c63c4.js" defer=""></script><script src="/_next/static/ETgvq8fq6HVMXEOqZ0XEc/_buildManifest.js" defer=""></script><script src="/_next/static/ETgvq8fq6HVMXEOqZ0XEc/_ssgManifest.js" defer=""></script></head><body><div id="__next"> <!-- --> <!-- --> <!-- --> <!-- --> <!-- --> <!-- --> <!-- --> <!-- --> <style type="text/css"> #onetrust-consent-sdk svg {display: inline;} </style><div id="root" data-sb-object-id="b2d3a7b3-3d10-40db-9391-04f990b2db83"><header data-sb-field-path="IV5sQe0KJfPcurPYxLZQeL:header" class="w-full shadow-lg flex items-center py-[20px] h-[90px] max-sm:h-[56px] px-[40px] max-sm:px-[20px] w-[100%] transition sticky z-[100] top-0 bg-white text-dark-grey"><a data-sb-field-path=".logo" class="flex items-center relative w-[96px] max-sm:w-[56px] ml-[-2px]" role="link" aria-label="Takeda Oncology" href="/"><div class="ImageBlock_root__xPYXG" style="aspect-ratio:2.7972972972972974"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Takeda logo" __metadata="[object Object]" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_image__2_PsU rounded-none" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover"/><noscript><img alt="Takeda logo" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_image__2_PsU rounded-none" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0"/></noscript></span></div></a><div class="flex items-center ml-auto"><div class="relative max-sm:static"><form role="combobox" aria-expanded="false" aria-haspopup="listbox" aria-labelledby="autocomplete-179-label"><div><div class="flex flex-row items-center search"><button aria-label="Search" type="button" class="m-[10px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 22 22" class="w-[22px] h-[22px] fill-current"><path d="M12.43.27a7.39,7.39,0,0,1,2-.27,7.51,7.51,0,0,1,3.81,1A7.81,7.81,0,0,1,21,3.75a7.51,7.51,0,0,1,1,3.81,7.58,7.58,0,0,1-1,3.82,8.28,8.28,0,0,1-1.19,1.53,7.72,7.72,0,0,1-3.33,1.95,7.74,7.74,0,0,1-4.59-.19,7.64,7.64,0,0,1-2.26-1.3L1.17,21.8a.69.69,0,0,1-1,0,.69.69,0,0,1,0-1L8.63,12.4a7.64,7.64,0,0,1-1.3-2.26,7.45,7.45,0,0,1-.45-2.58,7.49,7.49,0,0,1,.26-2,7.72,7.72,0,0,1,2-3.33A8.28,8.28,0,0,1,10.62,1,7.45,7.45,0,0,1,12.43.27Zm-.4,13a6.15,6.15,0,0,0,4.81,0,6.12,6.12,0,0,0,2-1.33,6.24,6.24,0,0,0,1.33-2,6.1,6.1,0,0,0,.48-2.41,6.05,6.05,0,0,0-.48-2.4,6.24,6.24,0,0,0-3.3-3.3,6.27,6.27,0,0,0-4.81,0,6.24,6.24,0,0,0-2,1.33,6.12,6.12,0,0,0-1.33,2,5.89,5.89,0,0,0-.49,2.4A5.94,5.94,0,0,0,8.74,10,6.3,6.3,0,0,0,12,13.26Z"></path></svg></button><div class="overflow-hidden transition-all max-sm:block max-sm:absolute max-sm:left-0 max-sm:top-[55px] max-sm:w-full w-0 max-sm:h-0"><div class="h-[35px] max-sm:h-[53px] w-full p-[10px] max-sm:p-0 bg-white text-dark-grey border-b-[1px] max-sm:border-[1px] border-b-light-grey max-sm:border-light-grey outline-none"><div class="flex flex-row justify-center w-min"><input aria-autocomplete="both" aria-labelledby="autocomplete-179-label" id="autocomplete-179-input" autoComplete="off" autoCorrect="off" autoCapitalize="off" enterKeyHint="search" spellcheck="false" maxLength="512" type="text" class="border-b outline-none p-0 max-sm:border-none max-sm:w-screen max-sm:h-full max-sm:!px-[5vw] max-sm:!py-[16px]" value=""/></div></div></div></div></div></form></div></div><button aria-label="Open menu" type="button" class="HamButton_root__yT8Rh ml-[65px] max-md:ml-[32px] max-sm:ml-[16px]" data-testid="hamburger"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="28" height="24" class="HamButton_icon__snr8j" role="img" aria-hidden="true" data-testid="icon-Hamburger"><rect width="100%" height="1"></rect><rect y="10.5" width="100%" height="1"></rect><rect y="21" width="100%" height="1"></rect></svg></button><div><div class="fixed inset-0 z-[100]" style="background:rgba(0, 0, 0, 0);visibility:hidden"><div class="relative max-w-[1920px] mx-auto"><aside class="absolute right-0 z-50 w-[500px] max-sm:w-screen h-screen bg-white text-dark-grey" style="opacity:0;box-shadow:-5px -1px 14px 0px rgba(0, 0, 0, 0);transform:translateX(100%) translateZ(0)"></aside></div></div></div></header><main><h1 class="sr-only">Embracing AI &amp; Emerging Technologies to Advance Cancer Care Oncology │ Leadership │ Article │ Data</h1><div data-sb-field-path="sections"><section data-section-position="0" data-sb-field-path="sections.0" data-section-name="# Embracing AI &amp; Emerging Technologies to Advance Cancer Care " data-exclude-from-nav="false" class="global-pt global-pb mt-0 global-mb max-sm:h-auto"><div class="relative"><div class="relative inset-0 min-h-[500px] max-sm:min-h-[200px]"><div class="relative h-[500px] max-sm:h-[200px] opacity-90 bg-white"><div class="ImageBlock_root__xPYXG"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Doctor silhouette digital" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_image__2_PsU rounded-none object-center" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover"/><noscript><img alt="Doctor silhouette digital" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_image__2_PsU rounded-none object-center" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/b_rgb:000000,o_60/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/b_rgb:000000,o_60/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/b_rgb:000000,o_60/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/b_rgb:000000,o_60/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/b_rgb:000000,o_60/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/b_rgb:000000,o_60/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image"/></noscript></span></div><div class="absolute inset-0 bg-black" style="opacity:0%"></div></div><div class="absolute bottom-0 left-0 w-11/12 px-14 pt-10 pb-8 bg-black/80 max-sm:relative max-sm:w-full max-sm:p-6 max-lg:px-8 max-lg:py-8"><hr class="absolute w-36 max-md:w-28 top-0 left-0 h-[6px] bg-primary border-none"/><div class="space-y-4"><div class="MarkdownRedesign_root__I9md6"><h2 class="MarkdownTitle_root__u5rUW !m-0 !font-light normal-case tracking-normal md:line-clamp-3 text-white" id="Embracing AI &amp; Emerging Technologies to Advance Cancer Care" data-sb-field-path=".title">Embracing AI &amp; Emerging Technologies to Advance Cancer Care</h2></div></div></div></div></div></section><section data-section-position="1" data-sb-field-path="sections.1" data-section-name="# Section Title" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__KEMgE BackButtonSection_container__vF7sj"><button class="BackButtonSection_button__gkxWl"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 18 14" class="BackButtonSection_icon__hiNy0" role="img" aria-hidden="false" data-testid="icon-ArrowBack"><title>Arrow back</title><path d="M6.7042 10.2945C7.09446 10.6853 7.09403 11.3184 6.70324 11.7087C6.31245 12.0989 5.67928 12.0985 5.28902 11.7077L0.29241 6.70427C-0.0976295 6.31369 -0.0974464 5.68096 0.29282 5.29061L5.28943 0.292966C5.67992 -0.0975982 6.31308 -0.0976639 6.70365 0.29282C7.09421 0.683304 7.09428 1.31647 6.70379 1.70703L3.411 5H10C14.3349 5 17.8645 8.44784 17.9962 12.7508L18 13C18 13.5523 17.5523 14 17 14C16.4477 14 16 13.5523 16 13C16 9.7616 13.4344 7.12243 10.2249 7.00414L10 7H3.414L6.7042 10.2945Z"></path></svg>Back</button></div></section><section data-section-position="2" data-sb-field-path="sections.2" data-section-name="" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white SectionWrapperWithTitle_root__CxgEB"><div class="Container_root__KEMgE SectionWrapperWithTitle_container__fUhBZ"><div data-sb-field-path=".rows"><div data-sb-field-path=".0"><div data-sb-field-path=".columns" class="grid grid-cols-2-1 max-lg:grid-cols-1" style="gap:20px 5%"><div data-sb-field-path=".0"><div data-sb-field-path=".components"><section data-sb-field-path=".0" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__KEMgE flex max-lg:flex-col max-lg:space-x-0 max-lg:space-y-[1.625rem] space-x-[4.375rem] text-dark-grey "><div class="flex-1 max-sm:w-full "><div class="ImageBlock_root__xPYXG !h-auto" style="aspect-ratio:1.7777777777777777"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img data-sb-field-path=".image.url" alt="Teresa Bitteti" __metadata="[object Object]" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_image__2_PsU rounded-bl-[20px]" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url(&quot;data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAATlBMVEX+//+pgWvT292kBUnm6+r5/P7Iy8ji6enq7+/f4+OvDk3h2N6yppfU0czKwrmUBj/OBGWab1uTJlDft9yGHziqLmC7borDn4bme77jD4QmRZZHAAAAPElEQVQIHQXBhwHAIAwEsQNM3ob0nv0XjYRHaB7NAZfsSZMDIetpG7xCSG87b6ug3L9WLgeGfKxl2aPyAz1oAfNrQmQ8AAAAAElFTkSuQmCC&quot;)"/><noscript><img data-sb-field-path=".image.url" alt="Teresa Bitteti" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_image__2_PsU rounded-bl-[20px]" sizes="(max-width: 640px) 100vw, 50vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn"/></noscript></span></div></div><div class="flex flex-col flex-1 max-sm:w-full self-center"><div class="break-words"><div class="MarkdownRedesign_root__I9md6"><div class="leading-[2rem]" data-sb-field-path=".richText"><p><strong>By Teresa Bitetti, President, Global Oncology Business Unit</strong></p><p>Recently, I’ve found the use of emerging technologies, like artificial intelligence (AI), and their wide-reaching potential to be an everyday topic of discussion for me and my colleagues at Takeda.</p></div></div></div></div></div></section><section data-sb-field-path=".1" class="global-pt global-pb global-mt global-mb bg-white flex flex-col justify-center border-none"><div class="Container_root__KEMgE"><div class="flex w-full max-w-screen-xl"><div class=""><div class="MarkdownRedesign_root__I9md6"><div class="TextBody_markdownText__3RZ9H" data-sb-field-path=".text"><p>Technology continues to evolve at a breakneck pace – from chatbots to AI-generated photos to virtual reality platforms – and increasingly I see new digital solutions become commonplace across most industries. While the adoption of these new technologies in the healthcare setting has been a bit slower compared to others, nowhere does it hold more potential to be transformative – especially in oncology.</p><p>As drug developers, embracing data and digital technologies can speed up treatment progress, accelerate the delivery of medicines and address patients&#x27; needs more effectively. The possibilities are endless, and I’m proud of how we are applying these tools at Takeda to help us solve problems – both big and small – and create efficiencies at all stages of development. I am particularly excited by the progress we are making with a few specific applications.</p></div></div></div></div></div></section><section data-sb-field-path=".2" class="global-pt global-pb global-mt global-mb bg-white flex flex-col justify-center border-none"><div class="Container_root__KEMgE"><div class="flex w-full max-w-screen-xl"><div class=""><div data-sb-field-path=".title" class="TextBody_markdownTitleWrapper___MMS_"><div class="MarkdownRedesign_root__I9md6"><div class="TextBody_markdownTitle__dhZAr text-dark-grey"><h2 id="Identifying Applications in Oncology">Identifying Applications in Oncology</h2></div></div><hr class="Divider_root____wNZ bg-primary TextBody_divider__DpshE"/></div><div class="MarkdownRedesign_root__I9md6"><div class="TextBody_markdownText__3RZ9H" data-sb-field-path=".text"><p>Clinical trial recruitment is crucial to the development of any investigational treatment. But with specific enrollment criteria to consider, it can be difficult to find the right patients. With the help of digital platforms and tools, we are analyzing data from diverse sources, allowing us to identify and enroll patients in trials more efficiently. One way we do this at Takeda is by leveraging available real-world data, clinical data and field intelligence to identify where eligible patients are located and set up clinical trial sites in those areas for a more targeted approach to recruitment. This may seem simple, but it is critical to consider the impact this could have in diversifying recruitment and streamlining clinical trials.</p><p>Once we have enrolled suitable patients in our trials, technology also helps us ensure our clinical trials stay on track. At Takeda, we continue to advance digital automation across our clinical supply chain, including using system-driven production planning to support automated ordering and distribution. This ensures that investigational therapies are available when needed to keep our studies moving forward. These applications ultimately help us accelerate trials and reduce the time it takes to make potential medicines available to patients.</p><p>Once a treatment is approved and available, technology can also help us better reach healthcare providers and improve patient treatment experience. One way it does this is by helping us create personalized experiences for each person to engage with based on their individual needs and preferences. Many of us experience this type of application often, such as when we log into a streaming platform like Netflix. Each Netflix user has a slightly different home screen based on their unique likes, dislikes and viewing history. Similarly, with the help of technology, our team leverages proprietary data and insights to create a custom experience for healthcare providers. It ensures we are reaching them at the right place and right time. We are also exploring ways to capture and analyze patient data on our treatments so we can partner with their providers to support things like adherence to therapy, health outcomes and quality of life.</p></div></div></div></div></div></section><section data-sb-field-path=".3" class="global-pt global-pb global-mt global-mb bg-white flex flex-col justify-center border-none"><div class="Container_root__KEMgE"><div class="flex w-full max-w-screen-xl"><div class=""><div data-sb-field-path=".title" class="TextBody_markdownTitleWrapper___MMS_"><div class="MarkdownRedesign_root__I9md6"><div class="TextBody_markdownTitle__dhZAr text-dark-grey"><h2 id="Paving the Way for Patients">Paving the Way for Patients</h2></div></div><hr class="Divider_root____wNZ bg-primary TextBody_divider__DpshE"/></div><div class="MarkdownRedesign_root__I9md6"><div class="TextBody_markdownText__3RZ9H" data-sb-field-path=".text"><p>While the unknown can be intimidating, by embracing new technology and treating it as another valuable tool in our arsenal – one that enhances versus replaces the human touch – we will address both complex problems and everyday tasks with increased efficiency and effectiveness.</p><p>It is clear that the healthcare industry has already begun to take steps in the right direction to maximize the benefits of these tools – I look forward to seeing how digital solutions, like the ones being incorporated by Takeda, can get us closer to our aspiration of finding a cure for cancer.</p><p>People living with cancer are waiting – let us work together to leverage the tools available in the service of patients and make a positive impact on the world.</p></div></div></div></div></div></section></div></div><div data-sb-field-path=".1"><div data-sb-field-path=".components"><section data-sb-field-path=".0" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__KEMgE"><div class="SocialShare_root__LpGjU"><button aria-label="twitter" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer;outline:none"><a tabindex="-1" class="group link SocialButtonDefault_root__61X6D SocialShare_socialRoot__Av1Vo" role="link" aria-label="Twitter" href="/"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 1200 1227" class="SocialButtonDefault_icon___u9BA SocialShare_socialIcon__gkbHG" role="img" aria-hidden="false" data-testid="icon-Twitter"><title>X</title><path d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg></a></button><button aria-label="facebook" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer;outline:none"><a tabindex="-1" class="group link SocialButtonDefault_root__61X6D SocialShare_socialRoot__Av1Vo" role="link" aria-label="Facebook" href="/"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="SocialButtonDefault_icon___u9BA SocialShare_socialIcon__gkbHG" role="img" aria-hidden="false" data-testid="icon-Facebook"><title>Facebook</title><path d="M24 12.073c0-6.627-5.373-12-12-12s-12 5.373-12 12c0 5.99 4.388 10.954 10.125 11.854v-8.385h-3.047v-3.47h3.047v-2.642c0-3.007 1.792-4.669 4.533-4.669 1.312 0 2.686 0.235 2.686 0.235v2.953h-1.514c-1.491 0-1.956 0.925-1.956 1.874v2.25h3.328l-0.532 3.47h-2.796v8.385c5.738-0.901 10.126-5.866 10.126-11.855z"></path></svg></a></button><button aria-label="linkedin" style="background-color:transparent;border:none;padding:0;font:inherit;color:inherit;cursor:pointer;outline:none"><a tabindex="-1" class="group link SocialButtonDefault_root__61X6D SocialShare_socialRoot__Av1Vo" role="link" aria-label="LinkedIn" href="/"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 22 21" class="SocialButtonDefault_icon___u9BA SocialShare_socialIcon__gkbHG" role="img" aria-hidden="false" data-testid="icon-LinkedIn"><title>LinkedIn</title><path d="M 0.24739583333333331 6.173705722070846 L 4.544270833333333 6.173705722070846 L 4.544270833333333 19 L 0.24739583333333331 19 L 0.24739583333333331 6.173705722070846 Z M 4.153645833333333 0.627724795640327 C 4.587673611111112 1.0462079927338777 4.809027777777779 1.5747048138056288 4.817708333333333 2.2132152588555862 C 4.826388888888889 2.8430971843778368 4.607204861111112 3.3694368755676645 4.16015625 3.7922343324250676 C 3.713107638888889 4.2150317892824685 3.125 4.4264305177111725 2.3958333333333335 4.4264305177111725 L 2.3697916666666665 4.4264305177111725 C 1.6579861111111114 4.4264305177111725 1.0850694444444446 4.2150317892824685 0.6510416666666667 3.7922343324250676 C 0.21701388888888884 3.3694368755676645 0 2.8430971843778368 0 2.2132152588555862 C 0 1.5747048138056288 0.22352430555555552 1.0462079927338777 0.6705729166666667 0.627724795640327 C 1.117621527777778 0.20924159854677427 1.7013888888888893 0 2.421875 0 C 3.142361111111111 0 3.719618055555556 0.20924159854677427 4.153645833333333 0.627724795640327 Z M 18.645833333333332 7.345027247956403 C 19.54861111111111 8.32436421435059 20 9.758855585831062 20 11.648501362397822 L 20 19 L 15.716145833333332 19 L 15.716145833333332 12.140326975476839 C 15.716145833333332 11.23433242506812 15.540364583333332 10.524636693914623 15.188802083333332 10.011239782016348 C 14.837239583333332 9.497842870118072 14.288194444444446 9.241144414168938 13.541666666666668 9.241144414168938 C 12.994791666666668 9.241144414168938 12.53689236111111 9.389986376021797 12.16796875 9.68767029972752 C 11.799045138888891 9.985354223433243 11.5234375 10.354223433242508 11.341145833333332 10.794277929155314 C 11.245659722222223 11.053133514986376 11.197916666666668 11.40258855585831 11.197916666666668 11.842643051771118 L 11.197916666666668 19 L 6.9140625 19 C 6.931423611111112 15.557220708446865 6.940104166666666 12.76589464123524 6.940104166666666 10.626021798365123 C 6.940104166666666 8.486148955495004 6.935763888888889 7.209128065395094 6.927083333333334 6.794959128065395 L 6.9140625 6.173705722070846 L 11.197916666666668 6.173705722070846 L 11.197916666666668 8.037465940054496 L 11.171875 8.037465940054496 C 11.34548611111111 7.761353315168028 11.5234375 7.51975476839237 11.705729166666668 7.312670299727522 C 11.888020833333332 7.105585831062671 12.133246527777779 6.881244323342415 12.44140625 6.639645776566757 C 12.749565972222223 6.398047229791097 13.127170138888891 6.210376930063577 13.57421875 6.076634877384197 C 14.021267361111114 5.942892824704814 14.518229166666668 5.876021798365122 15.065104166666668 5.876021798365122 C 16.549479166666668 5.876021798365122 17.743055555555557 6.365690281562215 18.645833333333332 7.345027247956403 Z"></path></svg></a></button></div></div></section><section data-sb-field-path=".1" class="bg-white StoriesSection_root__bZ_uW"><div class="Container_root__KEMgE StoriesSection_container__sXLwY"><div class="StoriesSection_header__aVRzT"><header class="SectionTitleContainer_root__FUs5_ text-dark-grey StoriesSection_titleContainer__cbxCK" data-testid="sectionTitleContainer"><div class="Markdown_root__yL_qp"><h3 id="Related Stories" class="StoriesSection_title__1Hls2" data-sb-field-path=".title">Related Stories</h3></div></header></div><div class="StoriesSection_articles__Nbcuc"><div class="StoriesSection_articleContainer__CuG9K"><a class="StoriesSection_articleLink__71Hlj" role="link" href="/news/our-viewpoints/embracing-innovation-how-todays-tech-is-transforming-translational-medicine-for-patients-with-cancer/"><div class="StoriesSectionItem_root__7mqxn StoriesSection_article__jdhLa"><div class="StoriesSectionItem_imageBlockWrapper__M4i9t"><div class="ImageBlock_root__xPYXG StoriesSectionItem_imageBlock__mc7yk" style="aspect-ratio:16/9"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Embracing Innovation: How Today’s Tech is Transforming Translational Medicine for Patients with Cancer" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_image__2_PsU ImageBlock_imageGlobalBorderRadius__1CbDr StoriesSectionItem_image__oug7S" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover"/><noscript><img alt="Embracing Innovation: How Today’s Tech is Transforming Translational Medicine for Patients with Cancer" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_image__2_PsU ImageBlock_imageGlobalBorderRadius__1CbDr StoriesSectionItem_image__oug7S" sizes="(max-width: 767px) 33vw, (max-width: 1200px) 15vw, 10vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_48/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 48w, https://assets-dam.takeda.com/image/upload/c_lfill,w_64/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 64w, https://assets-dam.takeda.com/image/upload/c_lfill,w_96/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 96w, https://assets-dam.takeda.com/image/upload/c_lfill,w_128/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 128w, https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9"/></noscript></span></div></div><div class="StoriesSectionItem_textWrapper__aEbFl"><p class="StoriesSectionItem_title__O4hfy">Embracing Innovation: How Today’s Tech is Transforming Translational Medicine for Patients with Cancer</p><span class="StoriesSectionItem_displayName__DMqNf">Data and Digital</span></div></div></a></div><div class="StoriesSection_articleContainer__CuG9K"><a class="StoriesSection_articleLink__71Hlj" role="link" href="/news/our-viewpoints/atlantic-rethink-qa-with-samer-ansari-takedas-oncology-business-unit-head-of-data-digital-technology/"><div class="StoriesSectionItem_root__7mqxn StoriesSection_article__jdhLa"><div class="StoriesSectionItem_imageBlockWrapper__M4i9t"><div class="ImageBlock_root__xPYXG StoriesSectionItem_imageBlock__mc7yk" style="aspect-ratio:16/9"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Atlantic Re:think Q&amp;A with Samer Ansari, Takeda’s Oncology Business Unit Head of Data, Digital &amp; Technology" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_image__2_PsU ImageBlock_imageGlobalBorderRadius__1CbDr StoriesSectionItem_image__oug7S" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover"/><noscript><img alt="Atlantic Re:think Q&amp;A with Samer Ansari, Takeda’s Oncology Business Unit Head of Data, Digital &amp; Technology" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_image__2_PsU ImageBlock_imageGlobalBorderRadius__1CbDr StoriesSectionItem_image__oug7S" sizes="(max-width: 767px) 33vw, (max-width: 1200px) 15vw, 10vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_48/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 48w, https://assets-dam.takeda.com/image/upload/c_lfill,w_64/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 64w, https://assets-dam.takeda.com/image/upload/c_lfill,w_96/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 96w, https://assets-dam.takeda.com/image/upload/c_lfill,w_128/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 128w, https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps"/></noscript></span></div></div><div class="StoriesSectionItem_textWrapper__aEbFl"><p class="StoriesSectionItem_title__O4hfy">Atlantic Re:think Q&amp;A with Samer Ansari, Takeda’s Oncology Business Unit Head of Data, Digital &amp; Technology</p><span class="StoriesSectionItem_displayName__DMqNf">Data and Digital</span></div></div></a></div></div></div></section></div></div></div></div></div></div></section></div></main><footer data-sb-field-path="IV5sQe0KJfPcurPYxLZQeL:footer" class="Footer_footer__FLo8i"><div class="Footer_wrapper__8NTjf"><div class="flex items-center max-lg:flex-col max-lg:items-start"><a class="Footer_logo__5v4_H" role="link" href="/"><div class="ImageBlock_root__xPYXG" style="aspect-ratio:2.8125"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img data-sb-field-path=".logo.url" alt="altText of the image" __metadata="[object Object]" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_image__2_PsU rounded-none" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover"/><noscript><img data-sb-field-path=".logo.url" alt="altText of the image" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_image__2_PsU rounded-none" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257"/></noscript></span></div></a><ul class="flex items-center ml-auto max-lg:ml-0 max-lg:mt-[24px]" data-sb-field-path="IV5sQe0KJfPcurPYxLZQeL:footer.socialLinks"><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".0"><a elementId="" __metadata="[object Object]" type="Social" class="group link Social_root__o_eDx SocialDefault_root__q7_ra" target="_blank" role="link" aria-label="Instagram" rel="noreferrer" href="http://www.instagram.com/TakedaOncology"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="Social_icon__VzKdr SocialDefault_icon__TItH1" role="img" aria-hidden="false" __metadata="[object Object]" type="Icon" data-testid="icon-Instagram"><title>Instagram</title><path d="M12 0c-3.26 0-3.667 0.015-4.947 0.072-1.278 0.060-2.148 0.261-2.913 0.558-0.789 0.306-1.459 0.717-2.126 1.384s-1.079 1.336-1.384 2.126c-0.297 0.765-0.499 1.635-0.558 2.913-0.060 1.28-0.072 1.687-0.072 4.947s0.015 3.667 0.072 4.947c0.060 1.277 0.261 2.148 0.558 2.913 0.306 0.788 0.717 1.459 1.384 2.126s1.336 1.079 2.126 1.384c0.766 0.296 1.636 0.499 2.913 0.558 1.28 0.060 1.687 0.072 4.947 0.072s3.667-0.015 4.947-0.072c1.277-0.060 2.148-0.262 2.913-0.558 0.788-0.306 1.459-0.718 2.126-1.384 0.666-0.667 1.079-1.335 1.384-2.126 0.296-0.765 0.499-1.636 0.558-2.913 0.060-1.28 0.072-1.687 0.072-4.947s-0.015-3.667-0.072-4.947c-0.060-1.277-0.262-2.149-0.558-2.913-0.306-0.789-0.718-1.459-1.384-2.126-0.667-0.667-1.335-1.079-2.126-1.384-0.765-0.297-1.636-0.499-2.913-0.558-1.28-0.060-1.687-0.072-4.947-0.072zM12 2.16c3.203 0 3.585 0.016 4.85 0.071 1.17 0.055 1.805 0.249 2.227 0.415 0.562 0.217 0.96 0.477 1.382 0.896 0.419 0.42 0.679 0.819 0.896 1.381 0.164 0.422 0.36 1.057 0.413 2.227 0.057 1.266 0.070 1.646 0.070 4.85s-0.015 3.585-0.074 4.85c-0.061 1.17-0.256 1.805-0.421 2.227-0.224 0.562-0.479 0.96-0.899 1.382-0.419 0.419-0.824 0.679-1.38 0.896-0.42 0.164-1.065 0.36-2.235 0.413-1.274 0.057-1.649 0.070-4.859 0.070-3.211 0-3.586-0.015-4.859-0.074-1.171-0.061-1.816-0.256-2.236-0.421-0.569-0.224-0.96-0.479-1.379-0.899-0.421-0.419-0.69-0.824-0.9-1.38-0.165-0.42-0.359-1.065-0.42-2.235-0.045-1.26-0.061-1.649-0.061-4.844 0-3.196 0.016-3.586 0.061-4.861 0.061-1.17 0.255-1.814 0.42-2.234 0.21-0.57 0.479-0.96 0.9-1.381 0.419-0.419 0.81-0.689 1.379-0.898 0.42-0.166 1.051-0.361 2.221-0.421 1.275-0.045 1.65-0.060 4.859-0.060l0.045 0.030zM12 5.838c-3.405 0-6.162 2.76-6.162 6.162 0 3.405 2.76 6.162 6.162 6.162 3.405 0 6.162-2.76 6.162-6.162 0-3.405-2.76-6.162-6.162-6.162zM12 16c-2.21 0-4-1.79-4-4s1.79-4 4-4 4 1.79 4 4-1.79 4-4 4zM19.846 5.595c0 0.795-0.646 1.44-1.44 1.44-0.795 0-1.44-0.646-1.44-1.44s0.646-1.439 1.44-1.439c0.793-0.001 1.44 0.645 1.44 1.439z"></path></svg></a></li><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".1"><a elementId="" __metadata="[object Object]" type="Social" class="group link Social_root__o_eDx SocialDefault_root__q7_ra" target="_blank" role="link" aria-label="facebook" rel="noreferrer" href="https://facebook.com/takedaoncology"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="Social_icon__VzKdr SocialDefault_icon__TItH1" role="img" aria-hidden="false" __metadata="[object Object]" type="Icon" data-testid="icon-Facebook"><title>Facebook</title><path d="M24 12.073c0-6.627-5.373-12-12-12s-12 5.373-12 12c0 5.99 4.388 10.954 10.125 11.854v-8.385h-3.047v-3.47h3.047v-2.642c0-3.007 1.792-4.669 4.533-4.669 1.312 0 2.686 0.235 2.686 0.235v2.953h-1.514c-1.491 0-1.956 0.925-1.956 1.874v2.25h3.328l-0.532 3.47h-2.796v8.385c5.738-0.901 10.126-5.866 10.126-11.855z"></path></svg></a></li><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".2"><a elementId="" __metadata="[object Object]" type="Social" class="group link Social_root__o_eDx SocialDefault_root__q7_ra" target="_blank" role="link" aria-label="Twitter" rel="noreferrer" href="https://twitter.com/takedaoncology"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 1200 1227" class="Social_icon__VzKdr SocialDefault_icon__TItH1" role="img" aria-hidden="false" __metadata="[object Object]" type="Icon" data-testid="icon-Twitter"><title>X</title><path d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg></a></li><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".3"><a elementId="" __metadata="[object Object]" type="Social" class="group link Social_root__o_eDx SocialDefault_root__q7_ra" target="_blank" role="link" aria-label="LinkedIn" rel="noreferrer" href="https://www.linkedin.com/company/takedaoncology"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 22 21" class="Social_icon__VzKdr SocialDefault_icon__TItH1" role="img" aria-hidden="false" __metadata="[object Object]" type="Icon" data-testid="icon-LinkedIn"><title>LinkedIn</title><path d="M 0.24739583333333331 6.173705722070846 L 4.544270833333333 6.173705722070846 L 4.544270833333333 19 L 0.24739583333333331 19 L 0.24739583333333331 6.173705722070846 Z M 4.153645833333333 0.627724795640327 C 4.587673611111112 1.0462079927338777 4.809027777777779 1.5747048138056288 4.817708333333333 2.2132152588555862 C 4.826388888888889 2.8430971843778368 4.607204861111112 3.3694368755676645 4.16015625 3.7922343324250676 C 3.713107638888889 4.2150317892824685 3.125 4.4264305177111725 2.3958333333333335 4.4264305177111725 L 2.3697916666666665 4.4264305177111725 C 1.6579861111111114 4.4264305177111725 1.0850694444444446 4.2150317892824685 0.6510416666666667 3.7922343324250676 C 0.21701388888888884 3.3694368755676645 0 2.8430971843778368 0 2.2132152588555862 C 0 1.5747048138056288 0.22352430555555552 1.0462079927338777 0.6705729166666667 0.627724795640327 C 1.117621527777778 0.20924159854677427 1.7013888888888893 0 2.421875 0 C 3.142361111111111 0 3.719618055555556 0.20924159854677427 4.153645833333333 0.627724795640327 Z M 18.645833333333332 7.345027247956403 C 19.54861111111111 8.32436421435059 20 9.758855585831062 20 11.648501362397822 L 20 19 L 15.716145833333332 19 L 15.716145833333332 12.140326975476839 C 15.716145833333332 11.23433242506812 15.540364583333332 10.524636693914623 15.188802083333332 10.011239782016348 C 14.837239583333332 9.497842870118072 14.288194444444446 9.241144414168938 13.541666666666668 9.241144414168938 C 12.994791666666668 9.241144414168938 12.53689236111111 9.389986376021797 12.16796875 9.68767029972752 C 11.799045138888891 9.985354223433243 11.5234375 10.354223433242508 11.341145833333332 10.794277929155314 C 11.245659722222223 11.053133514986376 11.197916666666668 11.40258855585831 11.197916666666668 11.842643051771118 L 11.197916666666668 19 L 6.9140625 19 C 6.931423611111112 15.557220708446865 6.940104166666666 12.76589464123524 6.940104166666666 10.626021798365123 C 6.940104166666666 8.486148955495004 6.935763888888889 7.209128065395094 6.927083333333334 6.794959128065395 L 6.9140625 6.173705722070846 L 11.197916666666668 6.173705722070846 L 11.197916666666668 8.037465940054496 L 11.171875 8.037465940054496 C 11.34548611111111 7.761353315168028 11.5234375 7.51975476839237 11.705729166666668 7.312670299727522 C 11.888020833333332 7.105585831062671 12.133246527777779 6.881244323342415 12.44140625 6.639645776566757 C 12.749565972222223 6.398047229791097 13.127170138888891 6.210376930063577 13.57421875 6.076634877384197 C 14.021267361111114 5.942892824704814 14.518229166666668 5.876021798365122 15.065104166666668 5.876021798365122 C 16.549479166666668 5.876021798365122 17.743055555555557 6.365690281562215 18.645833333333332 7.345027247956403 Z"></path></svg></a></li></ul></div></div><div class="Footer_footerNavigationWrapper__s8_1L"><div class="flex max-md:flex-col"><div></div></div></div><div class="mt-[72px] max-md:mt-[48px] font-sans px-[40px] max-sm:px-[20px] pb-8"><div class="Markdown_root__yL_qp"><div class="text-[16px] max-md:text-[14px] max-sm:text-[14x]" data-sb-field-path="IV5sQe0KJfPcurPYxLZQeL:footer.copyrightText"><p>All trademarks are the property of their respective owners.</p><p>©2024 Takeda Pharmaceuticals U.S.A., Inc.</p><p>All rights reserved.   01/23</p></div></div></div></footer><div class="BackToTopButton_root__UWnGG BackToTopButton_rootHidden__n18ZW"><button aria-label="Back to top" class="BackToTopButton_button__k2dGB" style="transform:scale(0) translateZ(0)"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 512 512" class="BackToTopButton_icon__w_yny" role="img" aria-hidden="false" data-testid="icon-BackToTop"><title>Back to top</title><path d="m512 256c0 141.386719-114.613281 256-256 256s-256-114.613281-256-256 114.613281-256 256-256 256 114.613281 256 256zm0 0"></path><g fill="white"><path d="m335.183594 184.558594-79.183594-79.183594-79.183594 79.183594 22.625 22.625 40.558594-40.558594v121.136719h32v-121.136719l40.558594 40.558594zm0 0"></path><path d="m240 319.761719h32v32h-32zm0 0"></path><path d="m240 383.761719h32v32h-32zm0 0"></path></g></svg></button></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"page":{"metaTitle":"Embracing AI \u0026 Emerging Technologies to Advance Cancer Care Oncology │ Leadership │ Article │ Data","canonical":"https://www.takedaoncology.com/news/our-viewpoints/embracing-AI-emerging-technologies-to-advance-cancer-care","enablePageNavigation":false,"addTitleSuffix":false,"site":{"header":{"searchPageUrl":"/search","localNavDefaultState":"","searchLocationPlaceholder":"Search for a country","searchPlaceholder":"Search...","title":"Takeda Oncology","version":"v2","scrolledDownColors":"takeda-colors","logo":{"aspectRatio":"","priority":false,"url":{"width":207,"version":1663597913,"resource_type":"image","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1663597913/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0.svg","access_mode":"public","height":74,"bytes":3077,"url":"http://res.cloudinary.com/takeda/image/upload/v1663597913/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0.svg","public_id":"TAKEDA GLOBAL/takeda_logo_1_pf4uo0","uploaded_by":{"id":"655351c881d79bafeab2ef825c88fb","type":"user"},"created_at":"2022-09-19T14:31:53Z","format":"svg","type":"cloudinary.asset","created_by":{"id":"655351c881d79bafeab2ef825c88fb","type":"user"},"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","altText":"Takeda logo","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAARVBMVEX94OL4rK/2i4/4naD4oqX1h4v4p6r809X6ur395eb5tLf6wsT7ysz5tbj2jpL809X4rK/2kJT70tT5rK/6xcf5tbj6xsilREIhAAAAFnRSTlP9BjroKoNC+aHXb+7v5qWq56ar///+Wg1+4gAAADBJREFUCB0FwQkCABAIBMBFJDfF/59qBo7KEZmFHPxeDHAfHjFc1asaIlJuZs9qTh8gVgGrrAdbegAAAABJRU5ErkJggg=="},"defaultColors":"takeda-colors","globalNavDefaultState":"expanded","__metadata":{"modelName":"DefaultHeader","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"9252634f-22e7-4042-ada9-0491a16c01b3","createdAt":"2022-07-21T14:11:36Z","updatedAt":"2023-06-08T11:31:39Z"},"type":"DefaultHeader"},"fallbackSocialImage":{"type":"cloudinary.asset","public_id":"legacy-dotcom/siteassets/ja-jp/home/takeda_logo","width":1080,"uploaded_by":{"type":"accesskey","id":"553579438111562"},"resource_type":"image","format":"svg","_version":1,"version":1675189033,"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"created_by":{"id":"553579438111562","type":"accesskey"},"secure_url":"https://assets-dam.takeda.com/image/upload/v1675189033/legacy-dotcom/siteassets/ja-jp/home/takeda_logo.svg","access_mode":"public","id":"b75fe16a3c7b8a0b4a272117d2e669af","created_at":"2023-01-31T18:17:13Z","height":599,"folder_id":"c190ec1e8b89091d82749269dcc568ea96","url":"http://assets-dam.takeda.com/image/upload/v1675189033/legacy-dotcom/siteassets/ja-jp/home/takeda_logo.svg","bytes":3685,"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"footer":{"socialLinks":[{"icon":{"variant":"Instagram","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"Instagram","url":"http://www.instagram.com/TakedaOncology","elementId":"","altText":"","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"altText":"facebook","icon":{"variant":"Facebook","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"Facebook","url":"facebook.com/takedaoncology","elementId":"","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"altText":"","icon":{"variant":"Twitter","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"Twitter","url":"https://twitter.com/takedaoncology","elementId":"","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"elementId":"","altText":"","icon":{"variant":"LinkedIn","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"LinkedIn","url":"https://www.linkedin.com/company/takedaoncology","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"}],"logo":{"url":{"uploaded_by":{"id":"553579438111562","type":"accesskey"},"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","width":720,"context":{"custom":{"Language":"English","alt":"Takeda logo","caption":"Takeda logo"}},"created_by":{"id":"553579438111562","type":"accesskey"},"format":"svg","tags":["Takeda Logo","Takeda","logo"],"resource_type":"image","created_at":"2022-05-11T09:09:23Z","version":1652260163,"type":"cloudinary.asset","height":256,"url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","bytes":3692,"access_mode":"public","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","altText":"altText of the image","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAAOVBMVEX4yMn86er4ycv0rrHuf4P3w8X50tNHcEz4zs/ugob73t/0rK763t/wlJfynaD86uv++PjzqKv1t7mDF9BrAAAADXRSTlP+Csdqs60qABrD7/7v1KBqGwAAAC1JREFUCNcdwgESABAIBMBLqJDw/8cydhZCnNpITAK1HrEWTJH3cZ9vRi34Sr0beAEtjhAsjAAAAABJRU5ErkJggg=="},"copyrightText":"All trademarks are the property of their respective owners.\n\n©2024 Takeda Pharmaceuticals U.S.A., Inc.\n\nAll rights reserved.   01/23\n","__metadata":{"modelName":"DefaultFooter","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"2fteZ9Y1L8iF6RDIFNFz2C","createdAt":"2022-09-20T09:31:47Z","updatedAt":"2024-01-05T15:39:47Z"},"type":"DefaultFooter"},"noIndexNoFollow":false,"scripts":[{"loadingStrategy":"beforeInteractive","title":"AIM-TAG","script":{"code":"\u003cscript defer nomodule src=\"https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer\u0026target=ie11\"\u003e\u003c/script\u003e\r\n\u003cscript defer type=\"module\" src=\"https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer\"\u003e\u003c/script\u003e\r\n\u003cscript defer\u003e\r\nwindow.aimDataLayer = window.aimDataLayer || [];\r\nfunction aimTag() { aimDataLayer.push(arguments); }\r\n// Transition event is temporary during a limited period of time to allow us to pull application cache from Legacy AIM Reader (v2) over to AIM Tag (v4)\r\naimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'transition');\r\naimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'pageview');\r\n// If your contract includes signal, then callback will include personal information on the visitor\r\naimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'signal', function(err, success) {\r\n if (err) {\r\n // This will occur if we disable your API Key\r\n console.log(err);\r\n } else {\r\n console.log(success);\r\n if (success.identity_type === \"AUT\") {\r\n // Handle signal callback here\r\n }\r\n }\r\n});\r\n\u003c/script\u003e","language":"js","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"OneTrust Script","script":{"code":"\u003c!-- OneTrust Cookies Consent Notice start for takedaoncology.com --\u003e\n\u003cscript defer type=\"text/javascript\" src=\"https://cdn.cookielaw.org/consent/1c21da89-fd19-457f-a6d0-69a1c4fead2d/OtAutoBlock.js\" \u003e\u003c/script\u003e\n\u003cscript defer src=\"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js\" data-document-language=\"true\" type=\"text/javascript\" charset=\"UTF-8\" data-domain-script=\"1c21da89-fd19-457f-a6d0-69a1c4fead2d\" \u003e\u003c/script\u003e\n\u003cscript defer type=\"text/javascript\"\u003e\nfunction OptanonWrapper() { }\n\u003c/script\u003e\n\u003c!-- OneTrust Cookies Consent Notice end for takedaoncology.com --\u003e","filename":"","language":"","highlightedLines":[2],"__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"GTA Script","script":{"language":"","code":"\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-WLM2GHB');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e","filename":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"script":{"code":"\u003c!-- Matomo Tag Manager --\u003e\u003cscript\u003e\nvar _mtm = window._mtm = window._mtm || [];\n_mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'});\nvar d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];\ng.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_8RFPFIX1.js'; s.parentNode.insertBefore(g,s);\n\u003c/script\u003e\u003c!-- End Matomo Tag Manager --\u003e","language":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"loadingStrategy":"beforeInteractive","title":"Matomo Tag Manager ","__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"script":{"language":"lorem-ipsum","code":"\u003cscript\u003e\n (function(h,o,u,n,d) {\n h=h[d]=h[d]||{q:[],onReady:function(c){h.q.push(c)}}\n d=o.createElement(u);d.async=1;d.src=n\n n=o.getElementsByTagName(u)[0];n.parentNode.insertBefore(d,n)\n })(window,document,'script','https://www.datadoghq-browser-agent.com/datadog-rum-v4.js','DD_RUM')\n \n DD_RUM.onReady(function() {\n DD_RUM.init({\n applicationId: 'cb52b5d9-3959-4471-83ab-4d3b7fc4413d', \n clientToken: 'pub03db37541acbf5d3c9cd0527f1ec4fcd', \n site: 'datadoghq.com', \n service: 'www.takedaoncology.com', \n env: 'prd', \n sampleRate: 100,\n sessionReplaySampleRate: 10,\n trackUserInteractions: true, \n trackResources: true, \n trackLongTasks: true, \n });\n \n DD_RUM.startSessionReplayRecording();\n })\n\u003c/script\u003e\n ","filename":"lorem-ipsum","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"loadingStrategy":"beforeInteractive","title":"Datadog Script","__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"CSS Hack for one trust","script":{"code":"\u003cstyle type=\"text/css\"\u003e #onetrust-consent-sdk svg {display: inline;} \u003c/style\u003e","filename":"","language":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"}],"exitDisclaimer":{"isEnabled":true,"description":"You are now leaving Takedaoncology.com and entering a website that is not owned or controlled by Takeda. \n\nTakeda Oncology makes no representation as to the accuracy of the information contained on websites we do not own or control. Takeda Oncology does not recommend or endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.\n","title":"You are now leaving Takedaoncology.com","cancelButtonTitle":"Cancel","okButtonTitle":"Continue","whitelistedUrls":["assets-dam.takeda.com","takedaoncology.com","www.takedaoncology.com","takeda.com","content.takeda.com","www.takeda.com","takeda.info","www.takeda.info","takedacanada.com","www.takedacanada.com","takedajobs.com/oncology","www.takedajobs.com/oncology","clinicaltrials.takeda.com","www.clinicaltrials.takeda.com","velcade.com","www.velcade.com","velcade-hcp.com","www.velcade-hcp.com","ninlaro.com","www.ninlaro.com","ninlarohcp.com","www.ninlarohcp.com","exkivityhcp.com","www.exkivityhcp.com","exkivity.com","www.exkivity.com","iclusig.com","www.iclusig.com","alunbrig.com","www.alunbrig.com","tsupportportal.com","www.tsupportportal.com","here2assist.com","www.here2assist.com","secure.ethicspoint.com/domain/media/en/gui/28267/index.html","takeda.envisionpharma.com/vt_takeda","cookiepedia.co.uk/giving-consent-to-cookies","www.cookiepedia.co.uk/giving-consent-to-cookies","instagram.com/TakedaOncology","www.instagram.com/TakedaOncology","twitter.com/takedaoncology","www.twitter.com/takedaoncology","facebook.com/takedaoncology","www.facebook.com/takedaoncology","linkedin.com/company/takedaoncology","www.linkedin.com/company/takedaoncology"],"__metadata":{"modelName":"ExitDisclaimer","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ExitDisclaimer"},"globalLanguages":[{"languageCode":"en","isDefault":false,"additionalLinks":[{"url":"https://www.takeda.com/privacy-notice/","elementId":"","showIcon":true,"label":"Privacy Notice","iconPosition":"right","altText":"Privacy Notice","icon":"LinkExternal","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"LinkExternal","showIcon":true,"elementId":"","label":"Terms of Use","altText":"","url":"https://www.takeda.com/terms-of-use/","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","iconPosition":"right","altText":"Social Media Policy","label":"Social Media Policy","showIcon":false,"icon":"arrowRight","url":"/social-media-policy/","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","altText":"","icon":"arrowRight","iconPosition":"right","showIcon":false,"label":"Contact Us","url":"/about/contact-us/","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"displayName":"English","links":[{"icon":"arrowRight","iconPosition":"right","label":"About","altText":"About Takeda Oncology","showIcon":false,"elementId":"","url":"/about/","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Science","icon":"arrowRight","url":"/science/","iconPosition":"right","label":"Science","showIcon":false,"elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","label":"Medicines","url":"/medicines/","altText":"Medicines","iconPosition":"right","showIcon":false,"elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"url":"/patients/","elementId":"","iconPosition":"right","altText":"Patients","icon":"arrowRight","label":"Patients","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Partnerships","elementId":"","icon":"arrowRight","label":"Partnerships","showIcon":false,"iconPosition":"right","url":"/partnerships/","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","showIcon":false,"label":"Newsroom ","elementId":"","altText":"Newsroom","icon":"arrowRight","url":"/newsroom/","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","showIcon":false,"url":"https://www.takeda.com/investors/","elementId":"","label":"Investors ","altText":"Investors","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"__metadata":{"modelName":"GlobalLanguage","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"GlobalLanguage"}],"__metadata":{"modelName":"Config","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"IV5sQe0KJfPcurPYxLZQeL","createdAt":"2022-07-21T14:11:21Z","updatedAt":"2024-06-12T10:12:02Z"},"type":"Config"},"socialImage":{"created_at":"2024-01-19T16:41:33Z","uploaded_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"folder_id":"c1e80517a809460d7004a5152963235b6c","resource_type":"image","created_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"height":1080,"public_id":"Takeda Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image","url":"http://assets-dam.takeda.com/image/upload/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png","format":"png","type":"cloudinary.asset","secure_url":"https://assets-dam.takeda.com/image/upload/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png","bytes":883719,"version":1705682493,"width":1920,"id":"ec1b8a618de47e04047a01fa10a0f314","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"access_mode":"public","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"noIndexNoFollow":false,"isBackToTopBtnEnabled":true,"keywords":"","description":"Technological advances continue to push the boundaries of what's possible. Takeda's Teresa Bitetti discusses how we are leveraging these tools for cancer patients.","title":"Embracing AI \u0026 Emerging Technologies to Advance Cancer Care","taxonomies":[{"displayName":"Data and Digital","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"j1tWZCfjdAwUaXU7wUc134","createdAt":"2022-12-16T17:49:34Z","updatedAt":"2023-06-08T11:32:09Z"},"type":"Taxonomy"}],"visibleInListings":true,"metaDescription":"Technological advances continue to push the boundaries of what's possible. Takeda's Teresa Bitetti discusses how we are leveraging these tools for cancer patients.","disableScrollRestoration":false,"headerPosition":"sticky","theme":{"colorPrimary":"#bd120a","textColor":"#333333","colorMediumGrey":"#8289A5","colorDarkGrey":"#34373f","colorSecondary":"#ffffff","colorMediumGreyContrast":"#ffffff","colorLightGreyContrast":"#34373f","colorSecondaryContrast":"#34373f","colorPrimaryContrast":"#ffffff","colorPrimaryActive":"#891515","colorPrimaryActiveContrast":"#ffffff","colorDarkGreyContrast":"#ffffff","colorLightGrey":"#edf2f4","__metadata":{"modelName":"ThemeStyle","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"2c32cbf6-3c2c-45c9-ba61-912e076f9e03","createdAt":"2022-09-02T06:01:20Z","updatedAt":"2023-06-08T11:31:22Z"},"type":"ThemeStyle"},"sections":[{"hideTitle":false,"titleColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"backgroundImageAlt":"Doctor silhouette digital","componentLayout":"takeda-com-redesign","excludeFromNavigation":false,"backgroundImagePosition":"center","backgroundImage":{"type":"cloudinary.asset","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"png","folder_id":"c1e80517a809460d7004a5152963235b6c","id":"ec1b8a618de47e04047a01fa10a0f314","width":1920,"secure_url":"https://assets-dam.takeda.com/image/upload/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png","uploaded_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"created_by":{"type":"user","id":"ec6a5b13a6920997f0770195fabdbb"},"version":1705682493,"bytes":883719,"height":1080,"url":"http://assets-dam.takeda.com/image/upload/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png","derived":[{"raw_transformation":"b_rgb:000000,o_60","secure_url":"https://assets-dam.takeda.com/image/upload/b_rgb:000000,o_60/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png","url":"http://assets-dam.takeda.com/image/upload/b_rgb:000000,o_60/v1705682493/Takeda%20Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image.png"}],"public_id":"Takeda Oncology/News/our-viewpoints/Teresa_DDT_Static_Article_Image","access_mode":"public","resource_type":"image","created_at":"2024-01-19T16:41:33Z","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"title":"# Embracing AI \u0026 Emerging Technologies to Advance Cancer Care\n\n","backgroundImageOpacity":0,"elementId":"","isNavigationShown":false,"displayName":"","__metadata":{"modelName":"PageBanner","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"PageBanner"},{"elementId":"","title":"# Section Title","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"excludeFromNavigation":false,"hideTitle":false,"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"displayName":"","__metadata":{"modelName":"BackButtonSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"BackButtonSection"},{"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"","elementId":"","displayName":"","excludeFromNavigation":false,"backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"hideTitle":false,"rows":[{"gridGap":5,"gridType":"2-1","columns":[{"components":[{"hideTitle":false,"media":[{"aspectRatio":"","priority":false,"url":{"uploaded_by":{"id":"655351c881d79bafeab2ef825c88fb","type":"user"},"type":"cloudinary.asset","access_mode":"public","bytes":23506,"width":800,"id":"b06488e91b9804c42af206ce02236ddf","created_at":"2022-08-05T15:19:32Z","url":"http://assets-dam.takeda.com/image/upload/v1659712772/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn.webp","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"resource_type":"image","version":1659712772,"folder_id":"c1374b5a4a09323dbf8fef14acb61c16ff","format":"webp","height":450,"secure_url":"https://assets-dam.takeda.com/image/upload/v1659712772/Takeda%20Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn.webp","created_by":{"id":"655351c881d79bafeab2ef825c88fb","type":"user"},"public_id":"Takeda Oncology/Leadership/takeda-oncology-leadership-headshot-teresa-bitetti_aettpn","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","altText":"Teresa Bitteti","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAGCAMAAADNLv/0AAAATlBMVEX+//+pgWvT292kBUnm6+r5/P7Iy8ji6enq7+/f4+OvDk3h2N6yppfU0czKwrmUBj/OBGWab1uTJlDft9yGHziqLmC7borDn4bme77jD4QmRZZHAAAAPElEQVQIHQXBhwHAIAwEsQNM3ob0nv0XjYRHaB7NAZfsSZMDIetpG7xCSG87b6ug3L9WLgeGfKxl2aPyAz1oAfNrQmQ8AAAAAElFTkSuQmCC"}],"excludeFromNavigation":false,"displayName":"","richText":"**By Teresa Bitetti, President, Global Oncology Business Unit**\n\nRecently, I’ve found the use of emerging technologies, like artificial intelligence (AI), and their wide-reaching potential to be an everyday topic of discussion for me and my colleagues at Takeda.","caption":"","titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"takeda-com-redesign","textPosition":"center","title":"","textColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"buttonPosition":"","mediaPosition":"left","elementId":"","__metadata":{"modelName":"MediaWithText","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"MediaWithText"},{"displayName":"","excludeFromNavigation":false,"text":"Technology continues to evolve at a breakneck pace – from chatbots to AI-generated photos to virtual reality platforms – and increasingly I see new digital solutions become commonplace across most industries. While the adoption of these new technologies in the healthcare setting has been a bit slower compared to others, nowhere does it hold more potential to be transformative – especially in oncology.\n\nAs drug developers, embracing data and digital technologies can speed up treatment progress, accelerate the delivery of medicines and address patients' needs more effectively. The possibilities are endless, and I’m proud of how we are applying these tools at Takeda to help us solve problems – both big and small – and create efficiencies at all stages of development. I am particularly excited by the progress we are making with a few specific applications.\n","elementId":"","componentLayout":"takeda-com-redesign","title":"","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"subtitle":"","hideTitle":false,"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"modelName":"TextSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"TextSection"},{"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"excludeFromNavigation":false,"subtitle":"","text":"Clinical trial recruitment is crucial to the development of any investigational treatment. But with specific enrollment criteria to consider, it can be difficult to find the right patients. With the help of digital platforms and tools, we are analyzing data from diverse sources, allowing us to identify and enroll patients in trials more efficiently. One way we do this at Takeda is by leveraging available real-world data, clinical data and field intelligence to identify where eligible patients are located and set up clinical trial sites in those areas for a more targeted approach to recruitment. This may seem simple, but it is critical to consider the impact this could have in diversifying recruitment and streamlining clinical trials.\n\nOnce we have enrolled suitable patients in our trials, technology also helps us ensure our clinical trials stay on track. At Takeda, we continue to advance digital automation across our clinical supply chain, including using system-driven production planning to support automated ordering and distribution. This ensures that investigational therapies are available when needed to keep our studies moving forward. These applications ultimately help us accelerate trials and reduce the time it takes to make potential medicines available to patients.\n\nOnce a treatment is approved and available, technology can also help us better reach healthcare providers and improve patient treatment experience. One way it does this is by helping us create personalized experiences for each person to engage with based on their individual needs and preferences. Many of us experience this type of application often, such as when we log into a streaming platform like Netflix. Each Netflix user has a slightly different home screen based on their unique likes, dislikes and viewing history. Similarly, with the help of technology, our team leverages proprietary data and insights to create a custom experience for healthcare providers. It ensures we are reaching them at the right place and right time. We are also exploring ways to capture and analyze patient data on our treatments so we can partner with their providers to support things like adherence to therapy, health outcomes and quality of life.\n","title":"## Identifying Applications in Oncology\n\n","elementId":"","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"hideTitle":false,"componentLayout":"takeda-com-redesign","displayName":"","__metadata":{"modelName":"TextSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"TextSection"},{"hideTitle":false,"displayName":"","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"takeda-com-redesign","title":"## Paving the Way for Patients\n\n","excludeFromNavigation":false,"subtitle":"","text":"While the unknown can be intimidating, by embracing new technology and treating it as another valuable tool in our arsenal – one that enhances versus replaces the human touch – we will address both complex problems and everyday tasks with increased efficiency and effectiveness.\n\nIt is clear that the healthcare industry has already begun to take steps in the right direction to maximize the benefits of these tools – I look forward to seeing how digital solutions, like the ones being incorporated by Takeda, can get us closer to our aspiration of finding a cure for cancer.\n\nPeople living with cancer are waiting – let us work together to leverage the tools available in the service of patients and make a positive impact on the world.\n","elementId":"","titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"modelName":"TextSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"TextSection"}],"__metadata":{"modelName":"ColumnSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnSection"},{"components":[{"elementId":"","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"# Section Title","socialShare":[{"twitter":true,"facebook":true,"linkedin":true,"__metadata":{"modelName":"SocialShare","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"SocialShare"}],"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"displayName":"","excludeFromNavigation":false,"hideTitle":false,"componentLayout":"default","__metadata":{"modelName":"SocialShareSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"SocialShareSection"},{"filterByTaxonomy":[{"displayName":"Data and Digital","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"j1tWZCfjdAwUaXU7wUc134","createdAt":"2022-12-16T17:49:34Z","updatedAt":"2023-06-08T11:32:09Z"},"type":"Taxonomy"}],"elementId":"","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"excludeFromNavigation":false,"hideTitle":false,"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"### Related Stories\n\n","displayName":"","count":3,"withDivider":false,"__metadata":{"modelName":"StoriesSectionAuto","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"StoriesSectionAuto","articles":[{"taxonomies":[{"displayName":"Data and Digital","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"j1tWZCfjdAwUaXU7wUc134","createdAt":"2022-12-16T17:49:34Z","updatedAt":"2023-06-08T11:32:09Z"},"type":"Taxonomy"},{"displayName":"our-viewpoints","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"E13B866B-3078-4828-ACC7-6843A32C1074","createdAt":"2022-12-12T06:39:00Z","updatedAt":"2023-06-08T11:31:45Z"},"type":"Taxonomy"}],"slug":"/news/our-viewpoints/embracing-innovation-how-todays-tech-is-transforming-translational-medicine-for-patients-with-cancer","publishDate":"2023-03-28T16:43:33.557Z","description":"Listen to Takeda’s Christine Ward, Ph.D., Head of Oncology and Cell Therapy Precision \u0026 Translational Medicine, and Julie Dixon, Ph.D., Head of Global Regulatory Affairs, as they answer this question and reflect on how data, digital and technology is transforming their work and redefining possibilities for the next era of oncology.","featuredImg":{"version":1680022105,"url":"http://assets-dam.takeda.com/image/upload/v1680022105/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9.png","bytes":2457072,"public_id":"Takeda Oncology/siteassets/news/our-viewpoints/Embracing Innovation How Todays Tech/Chris_Julie_OV_Masthead_16x9","secure_url":"https://assets-dam.takeda.com/image/upload/v1680022105/Takeda%20Oncology/siteassets/news/our-viewpoints/Embracing%20Innovation%20How%20Todays%20Tech/Chris_Julie_OV_Masthead_16x9.png","type":"cloudinary.asset","created_by":{"id":"b65c5b2ca94db1ce0f256859737814","type":"user"},"height":1350,"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"resource_type":"image","width":2400,"format":"png","uploaded_by":{"id":"b65c5b2ca94db1ce0f256859737814","type":"user"},"created_at":"2023-03-28T16:48:25Z","access_mode":"public","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"title":"Embracing Innovation: How Today’s Tech is Transforming Translational Medicine for Patients with Cancer","content":"Innovations in data, digital and technology continue to drive the latest advancements in oncology research, propelling us into the future of therapeutic development and identifying ways to more efficiently deliver new medicines to patients. As we learn to apply the tools provided by this field, we are offered the chance to discover and establish improved standards of care for people living with cancer. How can we use the latest technology to enhance our medicines and make a real difference in the lives of patients?\n\nListen to Takeda’s Christine Ward, Ph.D., Head of Oncology and Cell Therapy Precision \u0026 Translational Medicine, and Julie Dixon, Ph.D., Head of Global Regulatory Affairs, as they answer this question and reflect on how data, digital and technology is transforming their work and redefining possibilities for the next era of oncology.\n","readTime":0,"visibleInListings":true,"__metadata":{"modelName":"Article","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"L8gXOhwKS7iFWxmVXIEiks","createdAt":"2023-03-28T16:43:33Z","updatedAt":"2023-06-08T11:31:51Z"},"type":"Article"},{"readTime":0,"visibleInListings":true,"featuredImg":{"type":"cloudinary.asset","access_mode":"public","version":1674754507,"resource_type":"image","uploaded_by":{"id":"b65c5b2ca94db1ce0f256859737814","type":"user"},"created_at":"2023-01-26T17:35:07Z","width":800,"url":"http://res.cloudinary.com/takeda/image/upload/v1674754507/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps.jpg","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"jpg","created_by":{"id":"b65c5b2ca94db1ce0f256859737814","type":"user"},"bytes":49659,"public_id":"Takeda Oncology/News/Atlantic_2023_Q_A_r0jnps","secure_url":"https://res.cloudinary.com/takeda/image/upload/v1674754507/Takeda%20Oncology/News/Atlantic_2023_Q_A_r0jnps.jpg","height":450,"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"publishDate":"2023-01-26T14:00","title":"Atlantic Re:think Q\u0026A with Samer Ansari, Takeda’s Oncology Business Unit Head of Data, Digital \u0026 Technology","content":"*This piece of sponsored content was produced by Re:think, the content marketing studio at The Atlantic. This article was originally published on* [*Atlantic Re:think*](https://www.theatlantic.com/sponsored/takeda-2022/can-we-cure-cancer-with-data/3779/)*.*\n\n**Can We Cure Cancer with Data?**\n\nFounded in the 18th century as a traditional herbal medicine store in Osaka, Japan, Takeda has upheld a commitment to quality and innovation throughout its 240-year history. Today, as a global pharmaceutical company and a longtime innovator in the cancer research and treatment space, the organization is giving its Oncology Business Unit a dramatic data and digital transformation to better serve its patients at every step of their treatment journey. We spoke with Samer Ansari, the unit’s head of data, digital and technology, about why data and emerging technologies are critical to the discovery and development of new cancer treatments, and to the experience of patients and families suffering from these diseases.\n\n**Atlantic Re:think:** **Takeda’s Oncology Business Unit is unique in both structure and approach. Could you describe its mission and how emerging technology can play a role in achieving it?**\n\n**Samer Ansari:** Our business unit operates like a nimble biotech within a big pharmaceutical company, and it allows us to be very agile. That license to move with agility is fundamental because we are on a mission to cure cancer and must work with a sense of urgency—at the end of everything we do, there are patients waiting for innovative medicine to reach them as fast as possible. We are building industry-leading data and digital technologies that are helping us deliver on this commitment, enabling us to move at speed in our research and development and in our ability to reach people living with cancer.\n\n**Atlantic Re:think:** **What role do data and analytics play in cancer research and treatment?**\n\n**Samer Ansari:** Humans can only do so much in a small amount of time, and AI and machine learning are the augmenting factors that multiply what a human can achieve, ultimately creating greater efficiency and accuracy. The analogy I always think about is car racing. You can have the best car, but if the driver is not skilled enough to make those tight turns at the right time, the car alone cannot win the race. We have smart humans; we’ve cracked that. Now we’re empowering them with advanced data and technology capabilities to make sure that we can win the race for our patients.\n\nLet me give you an example: A key objective for us is to make sure that our clinical trials are inclusive and diverse, and we’re trying to connect the right patient with the right trial at the right time, anywhere in the world. Data and digital technologies are a key accelerator here as we can model large and complex data sets on a frequent basis, predicting where trial-eligible patients may be and which clinical trial sites can meet trial-specific diversity goals. This then helps us connect with the right people and sites through digital channels to ensure timely engagements.\n\n**Atlantic Re:think:** **What kind of organizations do you work with, and what is the nature of these partnerships? Why are these strategic partnerships important in the effort to treat, and ultimately cure, cancer?**\n\n**Samer Ansari:** Curing cancer is not something we can do alone. We’ve curated tremendous partnerships with leading pharmaceutical companies, health-care providers, diagnostic companies, hospital centers, community centers, academia and even the tech industry. In fact, I find that Takeda Oncology is increasingly reliant on digital innovation from outside of the health-care industry to aid in accelerating our efforts to discover, develop and deliver life-transforming cancer treatments. What these diverse partnerships have in common is that we share similar values and aim to create better experiences and outcomes for people living with cancer.\n\n**Atlantic Re:think:** **How does the era of hybrid physical-digital experience apply to cancer and oncology?**\n\n**Samer Ansari:** When it comes to early diagnosis of cancer, hybrid digital innovation can play a huge role. During the coronavirus pandemic, it was really heartbreaking to see that in-person diagnostics were delayed, and health-care professionals were finding out about patients’ illness much later in their cancer stage. Smart, small, nimble technology in people’s homes could provide early indicators through real-time data analytics to detect cancer in its earliest stages. It’s a huge unmet need and an even bigger opportunity to reshape the way we think about digital technology and the application of data. The industry has a long way to go in creating that holistic experience that is outcome-driven and value-based, and enables the patient to orchestrate a more personalized experience instead of making them undergo a standard experience from our company. I am proud of the fact that Takeda is already making progress with this mindset.\n\n**Atlantic Re:think:** **What are some of the challenges of working with new innovative forms of technology in the pharmaceutical industry?**\n\n**Samer Ansari:** All of us are on a learning journey to discover the ways in which unleashing the power of data and digital can impact how we work and what we can accomplish, including Takeda Oncology. I think companies that realize digital transformation isn’t a one-and-done shift, but a fast-evolving cultural change driven by innovative mindset, will be among the first to see improved performance and competitive positioning in their efforts to best serve people throughout their health-care journey. It is also extremely important to keep ethics and trust embedded in all our innovations, and that sense of responsibility is key.\n\n**Atlantic Re:think:** **What are the gaps in the current applications of technology that, once filled, could improve the cancer research and treatment experience?**\n\n**Samer Ansari:** Currently, early diagnosis and side-effect management is critical for the person living with cancer and for their caregiver. By monitoring the patient’s ongoing health progress on a real-time basis, we have access to more information that can help us, and their health-care providers, make better outcomes. The sooner we know, the more we know and the more we can help—that’s where there’s huge potential.\n","taxonomies":[{"displayName":"Data and Digital","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"j1tWZCfjdAwUaXU7wUc134","createdAt":"2022-12-16T17:49:34Z","updatedAt":"2023-06-08T11:32:09Z"},"type":"Taxonomy"},{"displayName":"our-viewpoints","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"E13B866B-3078-4828-ACC7-6843A32C1074","createdAt":"2022-12-12T06:39:00Z","updatedAt":"2023-06-08T11:31:45Z"},"type":"Taxonomy"}],"slug":"/news/our-viewpoints/atlantic-rethink-qa-with-samer-ansari-takedas-oncology-business-unit-head-of-data-digital-technology","description":"Founded in the 18th century as a traditional herbal medicine store in Osaka, Japan, Takeda has upheld a commitment to quality and innovation throughout its 240-year history. ","__metadata":{"modelName":"Article","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"kDhfvHIeclVE3PyeZPNNXs","createdAt":"2023-01-26T17:32:19Z","updatedAt":"2023-06-08T11:32:09Z"},"type":"Article"}]}],"__metadata":{"modelName":"ColumnSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnSection"}],"__metadata":{"modelName":"RowSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RowSection"}],"__metadata":{"modelName":"ColumnsRowsSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnsRowsSection"}],"slug":"/news/our-viewpoints/embracing-AI-emerging-technologies-to-advance-cancer-care","__metadata":{"modelName":"ContentLayout","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"b2d3a7b3-3d10-40db-9391-04f990b2db83","createdAt":"2024-01-19T15:42:51Z","updatedAt":"2024-10-10T21:20:58Z"},"type":"ContentLayout"},"site":{"exitDisclaimer":{"description":"You are now leaving Takedaoncology.com and entering a website that is not owned or controlled by Takeda. \n\nTakeda Oncology makes no representation as to the accuracy of the information contained on websites we do not own or control. Takeda Oncology does not recommend or endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.\n","title":"You are now leaving Takedaoncology.com","cancelButtonTitle":"Cancel","okButtonTitle":"Continue","whitelistedUrls":["assets-dam.takeda.com","takedaoncology.com","www.takedaoncology.com","takeda.com","content.takeda.com","www.takeda.com","takeda.info","www.takeda.info","takedacanada.com","www.takedacanada.com","takedajobs.com/oncology","www.takedajobs.com/oncology","clinicaltrials.takeda.com","www.clinicaltrials.takeda.com","velcade.com","www.velcade.com","velcade-hcp.com","www.velcade-hcp.com","ninlaro.com","www.ninlaro.com","ninlarohcp.com","www.ninlarohcp.com","exkivityhcp.com","www.exkivityhcp.com","exkivity.com","www.exkivity.com","iclusig.com","www.iclusig.com","alunbrig.com","www.alunbrig.com","tsupportportal.com","www.tsupportportal.com","here2assist.com","www.here2assist.com","secure.ethicspoint.com/domain/media/en/gui/28267/index.html","takeda.envisionpharma.com/vt_takeda","cookiepedia.co.uk/giving-consent-to-cookies","www.cookiepedia.co.uk/giving-consent-to-cookies","instagram.com/TakedaOncology","www.instagram.com/TakedaOncology","twitter.com/takedaoncology","www.twitter.com/takedaoncology","facebook.com/takedaoncology","www.facebook.com/takedaoncology","linkedin.com/company/takedaoncology","www.linkedin.com/company/takedaoncology"],"isEnabled":true,"__metadata":{"modelName":"ExitDisclaimer","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ExitDisclaimer"},"header":{"scrolledDownColors":"takeda-colors","defaultColors":"takeda-colors","searchLocationPlaceholder":"Search for a country","title":"Takeda Oncology","searchPageUrl":"/search","globalNavDefaultState":"expanded","localNavDefaultState":"","version":"v2","logo":{"elementId":"","altText":"Takeda logo","aspectRatio":"","priority":false,"url":{"access_mode":"public","uploaded_by":{"id":"655351c881d79bafeab2ef825c88fb","type":"user"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"version":1663597913,"url":"http://res.cloudinary.com/takeda/image/upload/v1663597913/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0.svg","resource_type":"image","format":"svg","public_id":"TAKEDA GLOBAL/takeda_logo_1_pf4uo0","bytes":3077,"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1663597913/TAKEDA%20GLOBAL/takeda_logo_1_pf4uo0.svg","height":74,"created_at":"2022-09-19T14:31:53Z","type":"cloudinary.asset","created_by":{"id":"655351c881d79bafeab2ef825c88fb","type":"user"},"width":207,"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAARVBMVEX94OL4rK/2i4/4naD4oqX1h4v4p6r809X6ur395eb5tLf6wsT7ysz5tbj2jpL809X4rK/2kJT70tT5rK/6xcf5tbj6xsilREIhAAAAFnRSTlP9BjroKoNC+aHXb+7v5qWq56ar///+Wg1+4gAAADBJREFUCB0FwQkCABAIBMBFJDfF/59qBo7KEZmFHPxeDHAfHjFc1asaIlJuZs9qTh8gVgGrrAdbegAAAABJRU5ErkJggg=="},"searchPlaceholder":"Search...","__metadata":{"modelName":"DefaultHeader","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"9252634f-22e7-4042-ada9-0491a16c01b3","createdAt":"2022-07-21T14:11:36Z","updatedAt":"2023-06-08T11:31:39Z"},"type":"DefaultHeader"},"fallbackSocialImage":{"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"created_by":{"id":"553579438111562","type":"accesskey"},"version":1675189033,"height":599,"width":1080,"bytes":3685,"id":"b75fe16a3c7b8a0b4a272117d2e669af","resource_type":"image","url":"http://assets-dam.takeda.com/image/upload/v1675189033/legacy-dotcom/siteassets/ja-jp/home/takeda_logo.svg","public_id":"legacy-dotcom/siteassets/ja-jp/home/takeda_logo","type":"cloudinary.asset","_version":1,"uploaded_by":{"type":"accesskey","id":"553579438111562"},"created_at":"2023-01-31T18:17:13Z","secure_url":"https://assets-dam.takeda.com/image/upload/v1675189033/legacy-dotcom/siteassets/ja-jp/home/takeda_logo.svg","folder_id":"c190ec1e8b89091d82749269dcc568ea96","format":"svg","access_mode":"public","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"noIndexNoFollow":false,"scripts":[{"loadingStrategy":"beforeInteractive","title":"AIM-TAG","script":{"code":"\u003cscript defer nomodule src=\"https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer\u0026target=ie11\"\u003e\u003c/script\u003e\r\n\u003cscript defer type=\"module\" src=\"https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer\"\u003e\u003c/script\u003e\r\n\u003cscript defer\u003e\r\nwindow.aimDataLayer = window.aimDataLayer || [];\r\nfunction aimTag() { aimDataLayer.push(arguments); }\r\n// Transition event is temporary during a limited period of time to allow us to pull application cache from Legacy AIM Reader (v2) over to AIM Tag (v4)\r\naimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'transition');\r\naimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'pageview');\r\n// If your contract includes signal, then callback will include personal information on the visitor\r\naimTag('b144cc67-6ce5-45f9-98b1-67b6555d21bd', 'signal', function(err, success) {\r\n if (err) {\r\n // This will occur if we disable your API Key\r\n console.log(err);\r\n } else {\r\n console.log(success);\r\n if (success.identity_type === \"AUT\") {\r\n // Handle signal callback here\r\n }\r\n }\r\n});\r\n\u003c/script\u003e","language":"js","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"OneTrust Script","script":{"highlightedLines":[2],"code":"\u003c!-- OneTrust Cookies Consent Notice start for takedaoncology.com --\u003e\n\u003cscript defer type=\"text/javascript\" src=\"https://cdn.cookielaw.org/consent/1c21da89-fd19-457f-a6d0-69a1c4fead2d/OtAutoBlock.js\" \u003e\u003c/script\u003e\n\u003cscript defer src=\"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js\" data-document-language=\"true\" type=\"text/javascript\" charset=\"UTF-8\" data-domain-script=\"1c21da89-fd19-457f-a6d0-69a1c4fead2d\" \u003e\u003c/script\u003e\n\u003cscript defer type=\"text/javascript\"\u003e\nfunction OptanonWrapper() { }\n\u003c/script\u003e\n\u003c!-- OneTrust Cookies Consent Notice end for takedaoncology.com --\u003e","filename":"","language":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"GTA Script","script":{"filename":"","language":"","code":"\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-WLM2GHB');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"script":{"code":"\u003c!-- Matomo Tag Manager --\u003e\u003cscript\u003e\nvar _mtm = window._mtm = window._mtm || [];\n_mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'});\nvar d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];\ng.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_8RFPFIX1.js'; s.parentNode.insertBefore(g,s);\n\u003c/script\u003e\u003c!-- End Matomo Tag Manager --\u003e","language":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"loadingStrategy":"beforeInteractive","title":"Matomo Tag Manager ","__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"script":{"language":"lorem-ipsum","code":"\u003cscript\u003e\n (function(h,o,u,n,d) {\n h=h[d]=h[d]||{q:[],onReady:function(c){h.q.push(c)}}\n d=o.createElement(u);d.async=1;d.src=n\n n=o.getElementsByTagName(u)[0];n.parentNode.insertBefore(d,n)\n })(window,document,'script','https://www.datadoghq-browser-agent.com/datadog-rum-v4.js','DD_RUM')\n \n DD_RUM.onReady(function() {\n DD_RUM.init({\n applicationId: 'cb52b5d9-3959-4471-83ab-4d3b7fc4413d', \n clientToken: 'pub03db37541acbf5d3c9cd0527f1ec4fcd', \n site: 'datadoghq.com', \n service: 'www.takedaoncology.com', \n env: 'prd', \n sampleRate: 100,\n sessionReplaySampleRate: 10,\n trackUserInteractions: true, \n trackResources: true, \n trackLongTasks: true, \n });\n \n DD_RUM.startSessionReplayRecording();\n })\n\u003c/script\u003e\n ","filename":"lorem-ipsum","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"loadingStrategy":"beforeInteractive","title":"Datadog Script","__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"CSS Hack for one trust","script":{"language":"","code":"\u003cstyle type=\"text/css\"\u003e #onetrust-consent-sdk svg {display: inline;} \u003c/style\u003e","filename":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"}],"footer":{"socialLinks":[{"label":"Instagram","url":"http://www.instagram.com/TakedaOncology","elementId":"","altText":"","icon":{"variant":"Instagram","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"altText":"facebook","icon":{"variant":"Facebook","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"Facebook","url":"facebook.com/takedaoncology","elementId":"","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"altText":"","icon":{"variant":"Twitter","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"Twitter","url":"https://twitter.com/takedaoncology","elementId":"","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"style":"link","label":"LinkedIn","url":"https://www.linkedin.com/company/takedaoncology","elementId":"","altText":"","icon":{"variant":"LinkedIn","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"}],"logo":{"elementId":"","altText":"altText of the image","aspectRatio":"","priority":false,"url":{"bytes":3692,"height":256,"access_mode":"public","uploaded_by":{"id":"553579438111562","type":"accesskey"},"created_at":"2022-05-11T09:09:23Z","format":"svg","type":"cloudinary.asset","url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","tags":["Takeda Logo","Takeda","logo"],"created_by":{"type":"accesskey","id":"553579438111562"},"public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","width":720,"resource_type":"image","secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","context":{"custom":{"Language":"English","alt":"Takeda logo","caption":"Takeda logo"}},"version":1652260163,"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAAOVBMVEX4yMn86er4ycv0rrHuf4P3w8X50tNHcEz4zs/ugob73t/0rK763t/wlJfynaD86uv++PjzqKv1t7mDF9BrAAAADXRSTlP+Csdqs60qABrD7/7v1KBqGwAAAC1JREFUCNcdwgESABAIBMBLqJDw/8cydhZCnNpITAK1HrEWTJH3cZ9vRi34Sr0beAEtjhAsjAAAAABJRU5ErkJggg=="},"copyrightText":"All trademarks are the property of their respective owners.\n\n©2024 Takeda Pharmaceuticals U.S.A., Inc.\n\nAll rights reserved.   01/23\n","__metadata":{"modelName":"DefaultFooter","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"2fteZ9Y1L8iF6RDIFNFz2C","createdAt":"2022-09-20T09:31:47Z","updatedAt":"2024-01-05T15:39:47Z"},"type":"DefaultFooter"},"globalLanguages":[{"isDefault":false,"additionalLinks":[{"icon":"LinkExternal","url":"https://www.takeda.com/privacy-notice/","elementId":"","altText":"Privacy Notice","iconPosition":"right","label":"Privacy Notice","showIcon":true,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"LinkExternal","elementId":"","label":"Terms of Use","url":"https://www.takeda.com/terms-of-use/","altText":"","iconPosition":"right","showIcon":true,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"icon":"arrowRight","iconPosition":"right","altText":"Social Media Policy","label":"Social Media Policy","elementId":"","url":"/social-media-policy/","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Contact Us","altText":"","iconPosition":"right","elementId":"","url":"/about/contact-us/","showIcon":false,"icon":"arrowRight","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"displayName":"English","links":[{"altText":"About Takeda Oncology","icon":"arrowRight","iconPosition":"right","showIcon":false,"url":"/about/","label":"About","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","url":"/science/","altText":"Science","showIcon":false,"icon":"arrowRight","label":"Science","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Medicines","showIcon":false,"iconPosition":"right","icon":"arrowRight","altText":"Medicines","url":"/medicines/","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Patients","elementId":"","altText":"Patients","iconPosition":"right","showIcon":false,"url":"/patients/","icon":"arrowRight","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Partnerships","iconPosition":"right","showIcon":false,"url":"/partnerships/","elementId":"","label":"Partnerships","icon":"arrowRight","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Newsroom","elementId":"","showIcon":false,"url":"/newsroom/","icon":"arrowRight","iconPosition":"right","label":"Newsroom ","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","icon":"arrowRight","showIcon":false,"elementId":"","altText":"Investors","label":"Investors ","url":"https://www.takeda.com/investors/","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"languageCode":"en","__metadata":{"modelName":"GlobalLanguage","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"GlobalLanguage"}],"__metadata":{"modelName":"Config","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"IV5sQe0KJfPcurPYxLZQeL","createdAt":"2022-07-21T14:11:21Z","updatedAt":"2024-06-12T10:12:02Z"},"type":"Config"},"defaultTheme":{"colorDarkGrey":"#34373f","textColor":"#333333","colorPrimaryActiveContrast":"#ffffff","colorPrimaryContrast":"#ffffff","colorMediumGreyContrast":"#ffffff","colorSecondary":"#ffffff","colorPrimary":"#bd120a","colorLightGreyContrast":"#34373f","colorSecondaryContrast":"#34373f","colorPrimaryActive":"#891515","colorMediumGrey":"#8289A5","colorDarkGreyContrast":"#ffffff","colorLightGrey":"#edf2f4","__metadata":{"modelName":"ThemeStyle","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"2c32cbf6-3c2c-45c9-ba61-912e076f9e03","createdAt":"2022-09-02T06:01:20Z","updatedAt":"2023-06-08T11:31:22Z"},"type":"ThemeStyle"}},"__N_SSG":true},"page":"/[[...slug]]","query":{"slug":["news","our-viewpoints","embracing-AI-emerging-technologies-to-advance-cancer-care"]},"buildId":"ETgvq8fq6HVMXEOqZ0XEc","isFallback":false,"dynamicIds":[39099,11735,40982,28378,11467,44676,48212,18079,30738,20675,286,42066,43829,47588,4818,16456,39413,53442,33644,2070,69838,37073,57158,79634,85365,48702,46787,98242,1118,14576,44330,70081,4432,73978,75724,5866,47133,98657,18091,53085,90288,60812,65657,61078,60283,65298,83029,46362,19457],"gsp":true,"scriptLoader":[]}</script></body></html>

Pages: 1 2 3 4 5 6 7 8 9 10